Science Publications

Sign Up
Sign In
Submit
Current Research in Public Health
Cite This Article Share Download PDF XML
  1. Home
  2. Journals
  3. Current Research in Public Health
  4. Archive
  5. Volume 4, Issue 1, 2025
  6. Article
Mini Review Open Access April 13, 2025

Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan

Masafumi Seki 1,*
1
Division of Infectious Diseases and Infection Control, Saitama Medical University International Medical Center, Hidaka City, Japan
Publihed in: Current Research in Public Health (Volume 4, Issue 1, 2025)
Page(s): 1-4
DOI: 10.31586/wjmm.2025.6069
Received
February 27, 2025
Revised
March 30, 2025
Accepted
April 08, 2025
Published
April 13, 2025
Keywords
Arexvy; Abrysvo; Elderly Persons; Respiratory Syncytial Virus; Viral Pneumonia; Vaccine
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2025. Published by Scientific Publications
Article metrics
Views
365
Downloads
69

Cite This Article

APA Style
Seki, M. (2025). Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan. Current Research in Public Health, 4(1), 1-4. https://doi.org/10.31586/wjmm.2025.6069
ACS Style
Seki, M. Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan. Current Research in Public Health 2025 4(1), 1-4. https://doi.org/10.31586/wjmm.2025.6069
Chicago/Turabian Style
Seki, Masafumi. 2025. "Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan". Current Research in Public Health 4, no. 1: 1-4. https://doi.org/10.31586/wjmm.2025.6069
AMA Style
Seki M. Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan. Current Research in Public Health. 2025; 4(1):1-4. https://doi.org/10.31586/wjmm.2025.6069 
@Article{crph6069,
AUTHOR = {Seki, Masafumi},
TITLE = {Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan},
JOURNAL = {Current Research in Public Health},
VOLUME = {4},
YEAR = {2025},
NUMBER = {1},
PAGES = {1-4},
URL = {https://www.scipublications.com/journal/index.php/WJMM/article/view/6069},
ISSN = {2831-5162},
DOI = {10.31586/wjmm.2025.6069},
ABSTRACT = {Respiratory syncytial virus (RSV) is commonly known as a pathogen of the bronchiolitis in children, however, recently also as a pathogen of the severe virus pneumonia in adults, especially elderly persons, and vaccines for elderly persons have been developed. There are two vaccines, such as the vaccines targeted for subgroup A with the adjuvant, and that targeted for both subgroup A and B but not included the adjuvant in Japan. Both vaccines are considered effective to prevent not only the incident of RSV infection/pneumonia, but also the exacerbations of the elderly persons with underlying diseases including chronic cardiopulmonary diseases.},
}
%0 Journal Article
%A Seki, Masafumi
%D 2025
%J Current Research in Public Health

%@ 2831-5162
%V 4
%N 1
%P 1-4

%T Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan
%M doi:10.31586/wjmm.2025.6069
%U https://www.scipublications.com/journal/index.php/WJMM/article/view/6069

TY  - JOUR
AU  - Seki, Masafumi
TI  - Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan
T2  - Current Research in Public Health
PY  - 2025
VL  - 4
IS  - 1
SN  - 2831-5162
SP  - 1
EP  - 4
UR  - https://www.scipublications.com/journal/index.php/WJMM/article/view/6069
AB  - Respiratory syncytial virus (RSV) is commonly known as a pathogen of the bronchiolitis in children, however, recently also as a pathogen of the severe virus pneumonia in adults, especially elderly persons, and vaccines for elderly persons have been developed. There are two vaccines, such as the vaccines targeted for subgroup A with the adjuvant, and that targeted for both subgroup A and B but not included the adjuvant in Japan. Both vaccines are considered effective to prevent not only the incident of RSV infection/pneumonia, but also the exacerbations of the elderly persons with underlying diseases including chronic cardiopulmonary diseases.
DO  - Respiratory Syncytial Virus Vaccines for the Elderly Population in Japan
TI  - 10.31586/wjmm.2025.6069
ER  -